This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by DesGroseillers, L Articles by Jolicoeur, P Search for Related Content PubMed PubMed Citation Articles by DesGroseillers, L Articles by Jolicoeur, P

 Previous Article  |  Next Article 

J Virol. 1984 December; 52(3): 945-952

The tandem direct repeats within the long terminal repeat of murine leukemia viruses are the primary determinant of their leukemogenic potential.

ABSTRACT

To map the viral sequences encoding the leukemogenic determinant(s) of nondefective murine leukemia viruses (MuLVs), we constructed chimeric viral genomes in vitro between cloned viral DNAs from the highly leukemogenic Gross passage A (Gross A) MuLV and from the related nonleukemogenic BALB/c N-tropic MuLV. Infectious chimeric MuLVs, recovered from murine cells microinjected with these DNAs, were inoculated into newborn mice to test the leukemogenic potential of these viruses. We found that the U3 long terminal repeat region from Gross A genomes was sufficient to confer an intermediate leukemogenic potential to chimeric MuLVs. Sequencing data indicated that the U3 tandem direct repeat was responsible for this effect. Adding most of the Gross A p15E-coding sequences to the Gross A U3 long terminal repeat enhanced the leukemogenic potential of chimeric viruses significantly. Adding a larger 3'-end env region (all p15E-coding sequences and 345 base pairs of the carboxy terminus of gp70) to the Gross A U3 long terminal repeat restored the full leukemogenic potential of Gross A MuLV. Chimeric viruses harboring only the Gross A 3'-end env region were, however, nonleukemogenic. Similar chimeric MuLVs, constructed with genomes from the parental weakly leukemogenic BALB/c B-tropic MuLVs and nonleukemogenic BALB/c N-tropic MuLVs, were also studied. Our data indicate that the U3 tandem direct repeat sequences appear to be necessary and sufficient to confer some leukemogenic potential to MuLV. However, env 3'-end sequences, mostly the p15E-encoding sequences, are required for the expression of fully leukemic phenotypes.

This article has been cited by other articles:

• Ejegod, D., Sorensen, K. D., Mossbrugger, I., Quintanilla-Martinez, L., Schmidt, J., Pedersen, F. S. (2009). Control of Pathogenicity and Disease Specificity of a T-Lymphomagenic Gammaretrovirus by E-Box Motifs but Not by an Overlapping Glucocorticoid Response Element. J. Virol. 83: 336-346 [Abstract] [Full Text]  
• Sorensen, K. D., Quintanilla-Martinez, L., Kunder, S., Schmidt, J., Pedersen, F. S. (2004). Mutation of All Runx (AML1/Core) Sites in the Enhancer of T-Lymphomagenic SL3-3 Murine Leukemia Virus Unmasks a Significant Potential for Myeloid Leukemia Induction and Favors Enhancer Evolution toward Induction of Other Disease Patterns. J. Virol. 78: 13216-13231 [Abstract] [Full Text]  
• Chao, S.-H., Walker, J. R., Chanda, S. K., Gray, N. S., Caldwell, J. S. (2003). Identification of Homeodomain Proteins, PBX1 and PREP1, Involved in the Transcription of Murine Leukemia Virus. Mol. Cell. Biol. 23: 831-841 [Abstract] [Full Text]  
• Wilson, C. A., Laeeq, S., Ritzhaupt, A., Colon-Moran, W., Yoshimura, F. K. (2002). Sequence Analysis of Porcine Endogenous Retrovirus Long Terminal Repeats and Identification of Transcriptional Regulatory Regions. J. Virol. 77: 142-149 [Abstract] [Full Text]  
• Nishigaki, K., Hanson, C., Thompson, D., Yugawa, T., Hisasue, M., Tsujimoto, H., Ruscetti, S. (2002). Analysis of the Disease Potential of a Recombinant Retrovirus Containing Friend Murine Leukemia Virus Sequences and a Unique Long Terminal Repeat from Feline Leukemia Virus. J. Virol. 76: 1527-1532 [Abstract] [Full Text]  
• DiFronzo, N. L., Leung, C. T., Mammel, M. K., Georgopoulos, K., Taylor, B. J., Pham, Q. N. (2002). Ikaros, a Lymphoid-Cell-Specific Transcription Factor, Contributes to the Leukemogenic Phenotype of a Mink Cell Focus-Inducing Murine Leukemia Virus. J. Virol. 76: 78-87 [Abstract] [Full Text]  
• Mertz, J. A., Mustafa, F., Meyers, S., Dudley, J. P. (2001). Type B Leukemogenic Virus Has a T-Cell-Specific Enhancer That Binds AML-1. J. Virol. 75: 2174-2184 [Abstract] [Full Text]  
• Ghosh, S. K., Roy-Burman, P., Faller, D. V. (2000). Long Terminal Repeat Regions from Exogenous but Not Endogenous Feline Leukemia Viruses Transactivate Cellular Gene Expression. J. Virol. 74: 9742-9748 [Abstract] [Full Text]  
• Ghosh, S. K., Faller, D. V. (1999). Feline Leukemia Virus Long Terminal Repeat Activates Collagenase IV Gene Expression through AP-1. J. Virol. 73: 4931-4940 [Abstract] [Full Text]  
• DiFronzo, N. L., Holland, C. A. (1999). Sequence-Specific and/or Stereospecific Constraints of the U3 Enhancer Elements of MCF 247-W Are Important for Pathogenicity. J. Virol. 73: 234-241 [Abstract] [Full Text]  
• Granger, S. W., Fan, H. (1998). In Vivo Footprinting of the Enhancer Sequences in the Upstream Long Terminal Repeat of Moloney Murine Leukemia Virus: Differential Binding of Nuclear Factors in Different Cell Types. J. Virol. 72: 8961-8970 [Abstract] [Full Text]  
• Barat, C., Rassart, E. (1998). Members of the GATA Family of Transcription Factors Bind to the U3 Region of Cas-Br-E and Graffi Retroviruses and Transactivate Their Expression. J. Virol. 72: 5579-5588 [Abstract] [Full Text]  
• Lovmand, J., Sorensen, A. B., Schmidt, J., Ostergaard, M., Luz, A., Pedersen, F. S. (1998). B-Cell Lymphoma Induction by Akv Murine Leukemia Viruses Harboring One or Both Copies of the Tandem Repeat in the U3 Enhancer. J. Virol. 72: 5745-5756 [Abstract] [Full Text]  
• Zaiman, A. L., Nieves, A., Lenz, J. (1998). CBF, Myb, and Ets Binding Sites Are Important for Activity of the Core I Element of the Murine Retrovirus SL3-3 in T Lymphocytes. J. Virol. 72: 3129-3137 [Abstract] [Full Text]  
• Starkey, C. R., Lobelle-Rich, P. A., Granger, S., Brightman, B. K., Fan, H., Levy, L. S. (1998). Tumorigenic Potential of a Recombinant Retrovirus Containing Sequences from Moloney Murine Leukemia Virus and Feline Leukemia Virus. J. Virol. 72: 1078-1084 [Abstract] [Full Text]  
• Speck, N A, Renjifo, B, Golemis, E, Fredrickson, T N, Hartley, J W, Hopkins, N (1990). Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity.. Genes Dev. 4: 233-242 [Abstract]